| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |